Last week we bought together both Sagittal Pharma Consulting and Essjay Solutions for the 2026 Offsite Meeting!

Over 50+ of our consultants and colleagues joined us for two days of discussion, challenge, insight and even a bit of magic!

We covered a lot of ground, including:

📌 CIOMS Benefit-Risk Framework
📌 ICH GCP E6 (R3) – Risk Expectations vs Reality
📌 How to Spot AI & an AI in PV Update
📌 Antisense Oligonucleotides & Clinical Safety
📌 Regulatory updates inc. Implementing Regulation, CIOMS updates, UK CTR & ICH E2D (R3)
📌 The Trusted Advisor – ‘Building Stronger Relationships’

For me, what stood out wasn’t just the topics… it was the quality of the debate.  Practical experience, different perspectives, healthy challenge and a shared focus on PV excellence.

Bringing this many experienced PV professionals together in one room over 2 days is a privilege. The energy, insight and openness in the discussions are exactly why we run our annual offsite, so a huge thank you to our attendees and our Essjay & Sagittal teams for making this such an exciting event!

Watch this space… video presentations coming soon!

Reflections from the DIA QPPV Forum 2025 – Amsterdam
AI in PV - What the CIOMS WG XIV Report Means in Practice